Trials / Conditions / Primary Hyperaldosteronism

Primary Hyperaldosteronism

13 registered clinical trials studyying Primary Hyperaldosteronism — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism NCT07007793	AstraZeneca	Phase 3
Active Not Recruiting	HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial) NCT05636995	Université de Sherbrooke	—
Recruiting	Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Stan NCT04278404	Duke University	—
Enrolling By Invitation	A Prospective Cohort Study for Patients With Adrenal Diseases NCT03474237	Seoul National University Hospital	—
Completed	Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producin NCT03405025	University College, London	N/A
Completed	Tissue K+ in Primary Hyperaldosteronism NCT04251780	University of Erlangen-Nürnberg Medical School	—
Completed	Dynamic Hormone Diagnostics in Endocrine Disease NCT02934399	Haukeland University Hospital	—
Completed	Primary Hyperaldosteronism and Ischemia-reperfusion Injury NCT01978132	Radboud University Medical Center	N/A
Completed	Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment NCT01728493	Radboud University Medical Center	—
Completed	Intraoperative Analysis of Cortisol During Adrenal Vein Sampling NCT01761344	Haukeland University Hospital	N/A
Completed	Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism NCT02938910	Assistance Publique - Hôpitaux de Paris	—
Completed	11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism NCT01567111	Helsinki University Central Hospital	N/A
Completed	Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism NCT00732771	Novartis	Phase 2